Brind.
  1. Oracle, Veeva, and DNAnexus are collaborating to advance life sciences platforms and cloud solutions, enhancing regulatory capabilities.

Veeva Systems reports use of Basics platform by 175+ biotechs

1 report, 1 independent Updated Oct 7
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Veeva Systems announced that more than 175 emerging biotechs are using Veeva Basics. This platform provides pre-configured and pre-validated applications for clinical, regulatory, quality, medical, and commercial functions. The applications help companies accelerate innovation while saving time, effort, and cost.

From prnewswire.com

Why it matters

Some supportBrind's analysis of the reports

The platform allows biotechs to replace manual or paper processes with industry-leading solutions. This capability helps high-growth companies improve compliance and speed up processes required for commercialization.

Oracle, Veeva, and DNAnexus are collaborating to advance life sciences platforms and cloud solutions, enhancing regulatory capabilities.

From prnewswire.com

Who's involved

  • Veeva SystemsProvides pre-configured applications to assist biotechs in meeting regulatory milestones.
  • FDAIs the regulatory agency whose milestones biotechs must meet.

Keep exploring

Part of

Oracle, Veeva, and DNAnexus are collaborating to advance life sciences platforms and cloud solutions, enhancing regulatory capabilities. All 2 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped